Market Exclusive

Analyst Activity – Leerink Swann Raises Its Price Target On ABIOMED (NASDAQ:ABMD) to $265.00

Analyst Ratings For ABIOMED (NASDAQ:ABMD)

Today, Leerink Swann raised its price target on ABIOMED (NASDAQ:ABMD) to $265.00 per share.

Some recent analyst ratings include

Recent Insider Trading Activity For ABIOMED (NASDAQ:ABMD)
ABIOMED (NASDAQ:ABMD) has insider ownership of 7.00% and institutional ownership of 90.75%.

Recent Trading Activity for ABIOMED (NASDAQ:ABMD)
Shares of ABIOMED closed the previous trading session at with 227.3300018310547 shares trading hands.

Exit mobile version